EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks. - Wikidata - wikimedia - TriplyDB

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

http://www.wikidata.org/entity/Q38609721

about

Preclinical Data on Efficacy of 10 Drug-Radiation Combinations: Evaluations, Concerns, and Recommendations Lung cancer cells that survive ionizing radiation show increased integrin α2β1- and EGFR-dependent invasiveness Lung Cancer Gene Signatures and Clinical Perspectives Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234 A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiation.Feasibility of cetuximab and chemoradiotherapy combination in Chinese patients with unresectable stage III non-small cell lung cancer: a preliminary report Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells.Torin2 Suppresses Ionizing Radiation-Induced DNA Damage Repair EGFR inhibition in non-small cell lung cancer: current evidence and future directions Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.Nontoxic concentration of DNA-PK inhibitor NU7441 radio-sensitizes lung tumor cells with little effect on double strand break repair.A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.Reversion of the ErbB malignant phenotype and the DNA damage response.Ionizing radiation-induced responses in human cells with differing TP53 status.Impact of Premature Senescence on Radiosensitivity Measured by High Throughput Cell-Based Assays.Multinucleated Giant Cancer Cells Produced in Response to Ionizing Radiation Retain Viability and Replicate Their Genome.The impact of autophagy on cell death modalities in CRL-5876 lung adenocarcinoma cells after their exposure to γ-rays and/or erlotinib.Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology.Spontaneous γH2AX Foci in Human Solid Tumor-Derived Cell Lines in Relation to p21WAF1 and WIP1 Expression.Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers Spatial and temporal distribution of γH2AX fluorescence in human cell cultures following synchrotron-generated X-ray microbeams: lack of correlation between persistent γH2AX foci and apoptosis.The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells.EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivity.The radiosensitizing effect of the aurora kinase inhibitors, ENMD-2076, on canine mast cell tumours in vitro.Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.Cellular and molecular properties of (90)Y-labeled cetuximab in combination with radiotherapy on human tumor cells in vitro.Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests.Mechanisms of skin aging induced by EGFR inhibitors.Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair Meeting report: Signal transduction meets systems biology.Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations.Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-α in human proximal tubular cells.

P2860

Q26767798-63C9D4AD-ECF2-405A-B8BA-C622A14B1FC7 Q27310015-D4DDEE67-F6BB-4CD5-862B-84AD0C3BC8B0 Q28387769-70344EE7-2FC6-46B5-BFBF-C51E25F91ED7 Q34000997-8DFDF27D-655D-41B4-91E2-042920C3973E Q34041735-8FAEC3BB-0111-4252-8F0A-5EE9A122A28F Q34050547-31218204-4725-4D28-9E97-99F4C1C65EDC Q34782417-D5F00820-2960-455A-A070-4654EE73E55B Q35538759-D4490FB5-34E9-4B8C-9F17-F4F0FEFDE240 Q35608002-39FDFA1C-3C6D-4E66-BC8E-895B2E3A7FB3 Q36073749-85201DB5-0365-4DE7-9664-60169459E1AA Q36500914-E7AC3607-B38E-4260-BEA3-5271DF8F52AF Q36560547-E0809FD9-F765-4550-A480-63F0F3746623 Q37041046-58E50CC9-94BD-48C0-9163-90D43E0DA2DB Q37180302-3AFA1E20-82D5-4936-AFDD-880E8AEB16E7 Q37189513-ACDFD5FE-CBF6-45EC-AC38-7CA6CF1A27B4 Q37252289-C7D177D9-5EE2-461E-9171-65E491E0784C Q37975010-4744B249-8E1D-4460-B8AA-82473235F771 Q38036571-433A4337-1230-40E8-82CF-60EB02E94A14 Q38047648-4FEED3C3-4620-41D1-AFDC-104211B4C139 Q38162722-DA01DD4F-A9EC-41D9-9F79-080F77F08410 Q38690266-F6EC5899-2D94-4758-83A2-611BD9D36FE9 Q38716153-FB81625B-F449-4906-96E4-C2A48C684CA2 Q38782471-54319E95-BE64-4C2C-A20F-35FEC5B77503 Q38869420-4DBF8BEC-831A-4217-AF74-5C228C9AB4A2 Q38871254-23B7DF64-F96F-41E2-8B52-515C36BE5E65 Q38880324-FA5E20AB-B1A2-4452-91FE-8896D5CA9F23 Q38911199-57566FC6-5045-42F5-9380-414F843C9609 Q38980408-C81BC989-0A1D-4D8F-BEBD-BF9CACD71819 Q38984960-0ABE86BD-076D-437E-BD71-BB8FBAA4F8BC Q39106976-35DAC28C-F4B0-4DDB-B932-E9B3EE97BE9D Q39140093-8BC683A3-CE0A-4DE4-B68F-150819CD73AA Q39150740-3DB9404C-66AE-44C3-B87B-60421C4DECAF Q39269601-BD01391E-9F70-4E35-B18B-C12FFC209DB9 Q39300555-DEEC4B13-4A9E-4077-9BD2-6F3E90DDB41C Q39696362-2E66D898-B300-4251-91C7-792139637E4A Q39778129-57AA465F-5CA1-4746-BCC6-D72CB287B382 Q39802972-47AAFBD8-194E-42D8-A80D-9C24547A20E9 Q41118609-84A708C4-89FD-4CDB-A5BB-E90D27E25386 Q41345101-F4F58A7B-7E2A-4318-B08A-EE3CD68245FD Q42234846-4FBE8DD8-161A-41D3-B07E-72DC9779A597

P2860

EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks.

http://www.wikidata.org/entity/Q38609721

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

EGF receptor inhibition radios ...... ning DNA double-strand breaks.

@en

type

label

EGF receptor inhibition radios ...... ning DNA double-strand breaks.

@en

prefLabel

EGF receptor inhibition radios ...... ning DNA double-strand breaks.

@en

P1433

Q38609721-0DFB58D4-7DCF-4F3F-88CB-347818BCBCCD

P1476

Q38609721-D094C925-F8D2-45DC-A489-F0E2537A4648

P2093

Q38609721-27DE7654-EF99-4DCF-9158-EFF46DDBC98D

Q38609721-4007A2D7-3BF0-48FC-8EC6-4021D1C0A9E8

Q38609721-62C5446A-3CC5-44E3-9DD7-723481EC0DE3

Q38609721-74AD5165-C107-486F-8183-BD4237DC2092

Q38609721-A06EF792-3B87-4ABD-903F-A506E8D33EB6

Q38609721-B80AF1BD-4A3A-44DB-B358-BF52382C57EC

Q38609721-BFA65364-A6AF-4C05-A5B1-A9EE07789B99

Q38609721-CF2885F9-C90D-44DE-AC9F-1D2C9B5828EE

Q38609721-D13C0D58-8045-4FDA-B101-0405F4C284E9

Q38609721-D3F3BDE4-3D00-4792-9B3A-4E082AEE5E2B

P2860

Q38609721-04A3D10B-88F6-4990-85A9-ED05AAE12515

Q38609721-0C31AA0C-B118-434A-9E9C-B8DCFE6DD6DC

Q38609721-0D27B50C-4DE9-49D4-9B3E-D6040AF259A1

Q38609721-0DA94290-79F8-478A-A8ED-BA92E7CBB0A9

Q38609721-31216DCD-7E24-4402-BDBA-0A15464A9703

Q38609721-3865C722-E62D-4096-BF7A-172B50E8CF8F

Q38609721-3CDF9473-FC2B-4AB7-BB4E-47604C13DB59

Q38609721-47D7F555-6D9E-495F-8439-B1A2F2A0C907

Q38609721-49FE515B-4AE5-4B5A-A3EE-F3EBF509DD2B

Q38609721-4F480D36-528C-4A58-A26A-2E2F05A72773

P304

Q38609721-3330D95F-08EA-4CB5-B936-DBA5FDCF03C9

P31

Q38609721-21615DDF-7533-492B-A805-88A186FDB6E3

P356

Q38609721-83A4F84A-8F3E-49A8-9F2A-59B43A8BF7C6

P407

Q38609721-A7027EDC-3DAF-4D62-876D-97C15E569FCE

P433

Q38609721-856AB0C5-3D53-4A6C-8022-04F10C81F5D7

P478

Q38609721-E69CABB4-F84E-43C5-B3B4-7F6F2ADC659F

P50

Q38609721-77B3F4F3-9FF8-40B1-B3FA-BFAA6B39B769

Q38609721-BEDCFF9D-36B4-4D53-9F11-F09E3840848B

P577

Q38609721-C0940B83-F8BC-4D4E-B164-A65684E2CD20

P698

Q38609721-B4FC6111-FB5D-45C7-A013-646275AEDE89

P932

Q38609721-6CEAC39F-ADC2-421A-B8A5-371761201F04

P356

0008-5472.CAN-11-0213

P1433

Cancer Research

P1476

EGF receptor inhibition radios ...... ning DNA double-strand breaks.

@en

P2093

Akash Nanda

http://www.w3.org/2001/XMLSchema#string

Cyril Benes

http://www.w3.org/2001/XMLSchema#string

David Sander

http://www.w3.org/2001/XMLSchema#string

Ekkehard Dikomey

http://www.w3.org/2001/XMLSchema#string

Fabian Morsbach

http://www.w3.org/2001/XMLSchema#string

Henning Willers

http://www.w3.org/2001/XMLSchema#string

Jeffrey Settleman

http://www.w3.org/2001/XMLSchema#string

Jochen Dahm-Daphi

http://www.w3.org/2001/XMLSchema#string

Liliana Gheorghiu

http://www.w3.org/2001/XMLSchema#string

Malte Kriegs

http://www.w3.org/2001/XMLSchema#string

P2860

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

The NCI60 human tumour cell line anticancer drug screen

Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?

Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?

Apoptosis, p53, and tumor cell sensitivity to anticancer agents.

Radiogenomics predicting tumor responses to radiotherapy in lung cancer

Lung cancer cell lines as tools for biomedical discovery and research

The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies.

Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.

P304

6261-6269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-0213

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

Michael Baumann

Mechthild Krause

P577

2011-08-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21852385

http://www.w3.org/2001/XMLSchema#string

P932

3185115

http://www.w3.org/2001/XMLSchema#string